PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA FOLLOWING TREATMENT WITH HIGH-DOSE METHOTREXATE

被引：0
|
作者：
Cappelli, Louis [1 ]
Newman, Jennifer [1 ]
Sharif, Muhammad [1 ]
Kayne, Allison [1 ]
Epperla, Narendranath [2 ]
Elguindy, Ahmed [2 ]
Palmer, Joshua [3 ]
Alnahhas, Iyad [1 ]
Shi, Wenyin [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Hosp, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NCOG-40
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High-dose methotrexate for elderly patients with newly diagnosed primary central nervous system lymphoma
    Zhu, J
    Mrugala, M
    Nugent, W
    Hochberg, F
    Batchelor, T
    ANNALS OF ONCOLOGY, 2005, 16 : 124 - 124
  • [2] Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients
    Guo, Yixian
    Lan, Xiaoxi
    Chang, Xiaoli
    Wang, Guoxiang
    Zou, Dongmei
    Su, Li
    Sun, Wanling
    BLOOD, 2021, 138
  • [3] High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma
    Gerard, Lauren M.
    Imrie, Kevin R.
    Mangel, Joy
    Buckstein, Rena
    Doherty, Mary
    Mackenzie, Robert
    Cheung, Matthew C.
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1882 - 1890
  • [4] Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
    Yuan, Xianggui
    Yu, Teng
    Huang, Yurong
    Jiang, Huawei
    Xu, Xiaohua
    Liang, Yun
    Qian, Wenbin
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [5] Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
    Xianggui Yuan
    Teng Yu
    Yurong Huang
    Huawei Jiang
    Xiaohua Xu
    Yun Liang
    Wenbin Qian
    Scientific Reports, 12 (1)
  • [6] HIGH-DOSE METHOTREXATE, HIGH-DOSE CYTARABINE AND TEMOZOLOMIDE FOR THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Salamoon, M.
    Hussein, T.
    Kenj, M.
    HAEMATOLOGICA, 2013, 98 : 355 - 355
  • [7] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
    Kansara, Roopesh
    Shenkier, Tamara N.
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    Gerrie, Alina S.
    Villa, Diego
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
  • [8] High-dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15-year multicenter experience
    Yoon, Wan-Soo
    Park, Jae-Sung
    Kim, Young-il
    Chung, Dong-Sup
    Jeun, Sin-Soo
    Hong, Yong-Kil
    Yang, Seung Ho
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (01) : 123 - 130
  • [9] High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL)
    Salamoon, Maher
    Hussein, Taisir
    Kenj, Mazen
    Bachour, Marrouan
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [10] Management of Patients With Primary Central Nervous System Lymphoma Treated With High-Dose Methotrexate
    Warnick, Elizabeth
    Auger, Danielle
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (02) : 177 - 180
12345